Klicken Sie auf den unteren Button, um den Inhalt von open.spotify.com zu laden.
Interview with Brett Hauber Ultimately, we work to improve patients lives but traditionally the voice of the patient was not important. However, over the last decades many stakeholders shift to include the patient more in the decision-making process and patients voice their needs and preferences more. Still capturing and evaluating
What aspects to consider? Are you early in your career and you could still go for a PhD in statistics? Do you wonder, if this pays out short and long-term? Is it worth the money? What are the long-term benefits or are there actually short term benefits as well?
Interview with Oliver Schoenborn-Kellenberger Do you want to change your job?Are you just looking for you first job?Do you consider to work for your own company or as a free-lancer? Then this episode will help you!
Interview with Maria Costa and Shahrul Mt-Isa Benefit-risk assessments are made by various stakeholders including sponsors, regulators, payers, physicians, and patients throughout the life-cycle of a treatment. The understanding of data plays a vital role in weighting positive and negative effects of medications. In this episode, we give you an
Interview with Kate Taylor – chair of the PSI conference in 2019 Hopefully, you’re attending statistical conferences to learn more about the latest developments in the field. But of course, there’s much more to conferences than just the sessions. In this episode, I’m chatting with Kate Taylor – the chair
Not all patients are created equal, but are there subgroups that are more homogenous? This episode follows the outline of a webinar, that I presented in 2018 during a PSI webinar. I’m introducing cluster analysis and why you as a statistician need to know about it. The title of the
Interview with Stephen Ruberg There’s a long tradition of statisticians working on clinical studies as well as other related data, e.g. pre-clinical data and observational data. In the advent of big data and data sciences, there’s a considerable pull from the business side of pharma to employ statistical approaches as
Interview with Ursula Garczarek Do you want to learn where the health sector might be heading in terms of data science? Do you understand the opportunities and barriers in terms of the application of data science? Are you prepared to learn the individual skills needed for these changes? Then this
It’s surely not the norm, that a statistician from the pharma sector ends up working for BBC. But Robert Cuffe has taken this step and needs to explain statistics to non-statisticians on a daily basis. In this episode, he shares the different methods he’s using. We also dive into common
Do you know that TransCelerate does for statisticians? Do you write study protocols, analysis plans and programming specifications as individual documents noting, that there’s lots of redundancy? Do you wonder, if there’s a more efficient was in-line with what regulators want?
Do you think, R can’t be used for regulatory submissions?Are you forced to use SAS but would like to use R instead?Would you like to understand how you can make R submission proof? Then this interview with Lyn Tailor and Craig McIlloney helps you. Both work on the PSI special
In this last part of the leadership series with Gary Sullivan, we talk about the next steps, you can take to work on your leadership skills. We cover the following areas: